Wei Feng Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Feng Shen has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Rui Yan Zhang
Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 shared publications Qi Zhang
Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, People's Republic of China
3 shared publicationsZhen Kun Yang
Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, People's Republic of China
3 shared publicationsFeng Hua Ding
Department of Cardiology, Rui Jin Hospital, Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China
2 shared publicationsJian Hu
2 shared publicationsLi Jin Pu
Institute of Cardiovascular Diseases, Shanghai Jiaotong University School of Medicine, Shanghai 200025, People's Republic of China
2 shared publications
Latest Publications
- Open Access
- 27 November 2018
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 17 (1) , 1-10
Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study
Negative coronary artery remodeling is frequent in patients with diabetes, but its mechanism remains unclear. We here evaluated the association of serum levels of glycated albumin (GA) and endogenous secretory receptor for advanced glycation end products (esRAGE) with coronary artery remodeling in type 2 diabetic patients. Serum levels of GA and esRAGE were measured and intravascular ultrasound was performed in 136 consecutive diabetic patients with 143 coronary intermediate lesions. The remodeling index (RI) was calculated as the ratio between external elastic membrane (EEM) area at the lesion site and EEM area at the reference segment. Negative remodeling (NR) was defined as an RI < 0.95 and intermediate or positive remodeling as an RI ≥ 0.95. Mean plaque burden at the lesion site was 70.96 ± 9.98%, and RI was 0.96 ± 0.18. Negative coronary arterial remodeling existed in 81 (56.6%) lesions. RI correlated closely with serum esRAGE level (r = 0.236, P = 0.005) and was inversely related to serum GA level (r = − 0.240, P = 0.004) and plasma low-density lipoprotein cholesterol (LDL-C) (r = − 0.206, P = 0.014) and total cholesterol levels (r = − 0.183, P = 0.028). Generalized estimating equations logistic regression analysis identified esRAGE (OR 0.037; 95% CI 0.012–0.564, P = 0.021), GA (OR 1.093; 95% CI 1.013–1.179, P = 0.018) and LDL-C (OR 1.479; 95% CI 1.072–2.835, P = 0.023) as independent predictors for negative remodeling. In diabetic patients, negative coronary artery remodeling is associated with increased GA and decreased esRAGE levels in serum.
- 27 November 2018
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 17 (1) , 1-10
Open AccessIncreased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study
Negative coronary artery remodeling is frequent in patients with diabetes, but its mechanism remains unclear. We here evaluated the association of serum levels of glycated albumin (GA) and endogenous secretory receptor for advanced glycation end products (esRAGE) with coronary artery remodeling in type 2 diabetic patients. Serum levels of GA and esRAGE were measured and intravascular ultrasound was performed in 136 consecutive diabetic patients with 143 coronary intermediate lesions. The remodeling index (RI) was calculated as the ratio between external elastic membrane (EEM) area at the lesion site and EEM area at the reference segment. Negative remodeling (NR) was defined as an RI < 0.95 and intermediate or positive remodeling as an RI ≥ 0.95. Mean plaque burden at the lesion site was 70.96 ± 9.98%, and RI was 0.96 ± 0.18. Negative coronary arterial remodeling existed in 81 (56.6%) lesions. RI correlated closely with serum esRAGE level (r = 0.236, P = 0.005) and was inversely related to serum GA level (r = − 0.240, P = 0.004) and plasma low-density lipoprotein cholesterol (LDL-C) (r = − 0.206, P = 0.014) and total cholesterol levels (r = − 0.183, P = 0.028). Generalized estimating equations logistic regression analysis identified esRAGE (OR 0.037; 95% CI 0.012–0.564, P = 0.021), GA (OR 1.093; 95% CI 1.013–1.179, P = 0.018) and LDL-C (OR 1.479; 95% CI 1.072–2.835, P = 0.023) as independent predictors for negative remodeling. In diabetic patients, negative coronary artery remodeling is associated with increased GA and decreased esRAGE levels in serum.
- 30 August 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 118 (11) , 1674-1679
Diabetes-Invoked High-Density Lipoprotein and Its Association With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
- 30 August 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 118 (11) , 1674-1679
Diabetes-Invoked High-Density Lipoprotein and Its Association With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
- 23 June 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 197, 241-247
Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease
- 23 June 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 197, 241-247
Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease
- 1 June 2004
- Vol. 43 (6) , 433-5
[Long-term outcomes after elective coronary stenting in diabetic patients].
To observe the long-term outcomes following coronary stenting in diabetic patients with coronary artery disease. This cohort study comprised 808 consecutive patients with coronary artery disease who underwent elective coronary stenting, including 174 diabetic patients and 634 non-diabetic patients. The long-term follow-up outcomes were compared. Procedural success rate was similar (96.0% vs 96.1%). Follow-up rate was 95.3%. Mean follow-up duration was (19 +/- 7.8) months (ranged from 6 to 42 months). Compared with non-diabetic patients, diabetic patients had less improvement of cardiac function (52.2% vs 61.0%), more re-admission (42.7% vs 32.5%), and higher occurrence rates of major adverse cardiac events (30.6% vs 22.2%), angiographic restenosis rate (19.1% vs 12.5%) and mortality (10.2% vs 4.6%). Logistic regression analysis indicated that diabetes mellitus was an independent predicator of death (odd ratio 2.20, 95% CI 1.12 approximately 4.33, P = 0.022) and restenosis (odd ratio 1.66, 95% CI 1.04 approximately 2.67, P = 0.035). Diabetic patients undergoing elective coronary stenting have acceptable long-term outcomes, but diabetes mellitus is still independently associated with worse late prognosis.
- 1 June 2004
- Vol. 43 (6) , 433-5
[Long-term outcomes after elective coronary stenting in diabetic patients].
To observe the long-term outcomes following coronary stenting in diabetic patients with coronary artery disease. This cohort study comprised 808 consecutive patients with coronary artery disease who underwent elective coronary stenting, including 174 diabetic patients and 634 non-diabetic patients. The long-term follow-up outcomes were compared. Procedural success rate was similar (96.0% vs 96.1%). Follow-up rate was 95.3%. Mean follow-up duration was (19 +/- 7.8) months (ranged from 6 to 42 months). Compared with non-diabetic patients, diabetic patients had less improvement of cardiac function (52.2% vs 61.0%), more re-admission (42.7% vs 32.5%), and higher occurrence rates of major adverse cardiac events (30.6% vs 22.2%), angiographic restenosis rate (19.1% vs 12.5%) and mortality (10.2% vs 4.6%). Logistic regression analysis indicated that diabetes mellitus was an independent predicator of death (odd ratio 2.20, 95% CI 1.12 approximately 4.33, P = 0.022) and restenosis (odd ratio 1.66, 95% CI 1.04 approximately 2.67, P = 0.035). Diabetic patients undergoing elective coronary stenting have acceptable long-term outcomes, but diabetes mellitus is still independently associated with worse late prognosis.